Target intelligence / Profile preview

Multiple antibiotic resistance protein MarR (MarR)

Target
MarR
Molecular classification
Transcription factor, Repressor, DNA-binding protein, Winged helix-turn-helix protein
01

Overview

Multiple antibiotic resistance protein MarR is a key transcriptional regulator in bacteria, particularly known for its role in mediating resistance to multiple antibiotics, oxidative stress, and organic solvents [1, 5, 13]. It is the prototypical member of the MarR family of transcription factors, characterized by a winged helix-turn-helix (wHTH) DNA-binding domain [2, 16]. Functioning primarily as a homodimeric repressor, MarR binds to the operator region of the marRAB operon, thereby limiting the production of the global activator MarA [5, 12, 15]. In the presence of specific ligands such as salicylate or certain environmental stressors, MarR undergoes allosteric changes that cause it to dissociate from the DNA [2, 13]. This dissociation allows for the upregulation of multidrug efflux pumps, such as AcrAB-TolC, and the downregulation of porins, facilitating a survival response [12, 15]. This regulatory mechanism makes MarR a critical determinant of clinical antibiotic resistance in pathogens like Escherichia coli and Staphylococcus aureus [1, 9, 13]. Consequently, it is considered an attractive target for novel antimicrobial strategies aimed at preventing the induction of resistance pathways [1, 5, 6].

Other names
Multiple antibiotic resistance regulatorRepressor of the marRAB operoncfxBinaRsoxQ
02

Mechanism of action

MarR functions as a transcriptional repressor of the marRAB operon; allosteric inactivation by small-molecule ligands or oxidation induces derepression of resistance genes [5, 6, 13].

03

Biological functions

Transcription regulationAntibiotic resistanceOxidative stress responseVirulence regulationAcid stress resistanceMetabolic regulation
04

Disease associations

InfectionMultidrug-resistant infectionTuberculosis
05

Safety considerations

Potential for inadvertent induction of multidrug resistance if the target is partially activatedChallenges in achieving selectivity among various MarR family membersHigh intracellular concentration requirements for known natural ligands to achieve effect
06

Interacting drugs

Salicylate

3 more in the full profile.

07

Biomarkers

marR gene mutationsMarA expression levelsmarRAB operon expression

Beyond the preview

Go deeper on Multiple antibiotic resistance protein MarR (MarR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple antibiotic resistance protein MarR (MarR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call